An oxygen-generating implant keeps high-density insulin-producing cells alive in diabetic rats for months without immune suppression.

Bayer will partner with Kumquat Biosciences to develop Kumquat’s KRAS G12D inhibitor, which could generate $1.3 billion-plus for the San Diego biotech.

Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.

Knocking down EPIC1 sensitized triple negative breast tumor-bearing mice to immunotherapy with the PD-1 inhibitor pembrolizumab.

The enhanced hybrid model improves the predictive capability of data-driven modeling and reduces the need for process knowledge.

In search of a better approach to designing and developing these small proteins, researchers turned to ProtGPT2.

AIs are as much a tool as a hammer or shovel, but to find the opportunities, we need to understand what the realities and risks are.

Surging demand for vectors has also prompted suppliers to explore novel transfection technologies—including electroporation or transposon-based systems—to improve yield. Traditional methods rely on ...

The AI tool, named “Pythia,” predicts how cells repair their DNA after CRISPR editing and opens the door to next-generation gene therapies.